. 2021 Dec 1;11:759595. doi: 10.3389/fonc.2021.759595

Table 4.

Comparison of total cholesterol (TC) level at different time-points over the course of treatment.

Group	Baseline	3 months	6 months	9 months	12 months	18 months	24 months	36 months	48 months	60 months
TAM group	4.15 ± 0.79	4.31 ± 0.83	4.22 ± 1.00	4.11 ± 0.76	4.10 ± 0.85	4.22 ± 0.85	4.30 ± 0.76	4.18 ± 0.64	4.36 ± 0.75^#	4.30 ± 0.75^#
(n)	(81)	(56)	(51)	(39)	(64)	(52)	(59)	(48)	(38)	(23)
TAM+OFS group	4.25 ± 0.87	4.42 ± 0.91	4.42 ± 0.82	4.30 ± 0.83	4.23 ± 0.75	4.37 ± 0.76	4.37 ± 0.74	4.40 ± 0.68*	4.58 ± 0.99*^#	4.36 ± 0.89
(n)	(61)	(48)	(42)	(38)	(49)	(42)	(50)	(41)	(39)	(29)
F_inter-group=7.288, P _inter-group<0.05;F_intra-group=4.353, P _intra-group<0.001
TAM group	4.15 ± 0.79	4.31 ± 0.82	4.22 ± 1.00	4.11 ± 0.76	4.10 ± 0.85	4.22 ± 0.85	4.30 ± 0.76	4.18 ± 0.64	4.36 ± 0.75^#	4.30 ± 0.75^#
(n)	(81)	(56)	(51)	(39)	(64)	(52)	(59)	(48)	(38)	(23)
AI+OFS group	4.26 ± 0.85	4.47 ± 0.90	4.55 ± 0.84*#	4.48 ± 0.73*	4.48 ± 0.85*	4.50 ± 0.90*^#	4.60 ± 0.92*^#	4.70 ± 1.05*^#	4.61 ± 0.95*^#	4.87 ± 0.93*^#
(n)	(88)	(73)	(70)	(58)	(76)	(68)	(67)	(58)	(48)	(37)
F_inter-group=77.203, P _inter-group<0.001;F_intra-group=13.443, P _intra-group<0.001
TAM+OFS group	4.25 ± 0.87	4.42 ± 0.91	4.42 ± 0.82	4.30 ± 0.83	4.23 ± 0.75	4.37 ± 0.76	4.37 ± 0.74	4.40 ± 0.68	4.58 ± 0.99^#	4.36 ± 0.89
(n)	(61)	(48)	(42)	(38)	(49)	(42)	(50)	(41)	(39)	(29)
AI+OFS group	4.26 ± 0.85	4.47 ± 0.90	4.55 ± 0.84^#	4.48 ± 0.73	4.48 ± 0.85*	4.50 ± 0.90^#	4.60 ± 0.92^#	4.70 ± 1.05*^#	4.61 ± 0.95^#	4.87 ± 0.93*^#
(n)	(88)	(73)	(70)	(58)	(76)	(68)	(67)	(58)	(48)	(37)
F_inter-group=19.462, P _inter-group<0.001;F_intra-group=3.696, P _intra-group<0.001

n represents patient number.

*P value < 0.05, compared to the other group at the same time-point.

^#P value < 0.05, compared to the baseline at the same group.